X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

PhRMA CEO discusses industry’s new approach to DTC television advertising

By Holly Campbell  |    October 17, 2018
PhRMA president and CEO Stephen J. Ubl joined CBS This Morning and MSNBC Live with Ali Velshi to discuss PhRMA member companies’ commitment to providing patients with the information they need to...   Read More

FDA needs best and brightest to advance a new era of medicine with America’s biopharmaceutical companies

By Richard Moscicki, M.D.  |    October 16, 2018
The U.S Food and Drug Administration (FDA) plays a critical role in protecting and promoting the health of all Americans. Every day, the FDA does important work to ensure the safety, efficacy and...   Read More

What they are saying: PhRMA member executives on industry’s new approach to DTC television advertising

By Holly Campbell  |    October 15, 2018
Pharmaceutical Research and Manufacturers of America (PhRMA) member companies today announced their commitment to providing more transparency about medicine costs to help patients make more...   Read More

Americans want to know more than just the list price of a medicine—and we’re answering their call

By Robert Zirkelbach  |    October 15, 2018
The biopharmaceutical industry is answering the call to provide more information about medicine costs. As innovators of life-saving therapies, we recognize the importance of giving people the...   Read More

Balancing innovation and competition in the biologics marketplace

By David Korn  |    October 11, 2018
Last month, I presented at the U.S. Food and Drug Administration’s (FDA) Public Hearing on Facilitating Competition and Innovation in the Biological Products Marketplace. The hearing was part of...   Read More

Report: Corporate venture capital is catalyzing groundbreaking biomedical innovation in the United States

By Anne McDonald Pritchett, PhD  |    October 10, 2018
Venture capital is increasingly becoming the growing force for financing biotech and other startups, fueling medical advances in the U.S.  A new report released today from TEConomy, examines the...   Read More

ICYMI: Wall Street Journal highlights dangers of counterfeit medicines entering the United States through drug importation

By Nicole Longo  |    October 9, 2018
This week, the Wall Street Journal took a closer look at the very real threat drug importation poses, detailing how such schemes expose Americans to dangerous counterfeit medicines. The reporter...   Read More

Coupons allow patients to remain on medicines in spite of high cost sharing and deductibles

By Katie Koziara  |    October 4, 2018
According to a new report by IQVIA Institute for Human Data Science, more and more patients are asked to pay high cost sharing due to changes in benefit design. Previous analysis has shown that...   Read More

Examining the truth behind clinical trial costs

By John Corea  |    October 2, 2018
Last week, a study appearing in the Journal of the American Medical Association (JAMA) Internal Medicine, evaluated the costs specifically associated with successful clinical trials for novel...   Read More

Event tomorrow: Leaders convene to discuss solutions to advance value-driven health care

By Katie Koziara  |    October 2, 2018
Tomorrow, October 3, PhRMA will convene health care leaders for a discussion on how we can move our health care system toward one focused on value rather than volume, ensuring patients can access...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates